Apoptosis and p53 suppressor gene protein expression in human anterior pituitary adenomas

European Journal of Endocrinology

Volumn 136, Issue 4, 1997, Pages 382-387

  Green, Victoria L ^a   White, Michael C ^a   Hipkin, Leslie J ^b   Jeffreys, Richard V ^c   Foy, Patrick M ^c   Atkin, Stephen L ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c WALTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADENOHYPOPHYSIS; ADULT; AGED; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; MALE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; TUMOR VOLUME;

EID: 0030926772     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1360382     Document Type: Article

References (31)

1. Alexander JM, Biller BMK, Bikkal H, Zervas NT, Arnold A & Klibanski A. Clinically non functioning pituitary tumors are monoclonal in origin. Journal of Clinical Investigation 1990 86 336-340.
2. Herman V, Fagin J, Gonsky R, Kovacs K & Melmed S. Clonal origin of pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 1990 71 1427-1433.
3. Boggild MD, Jenkinson S, Pistorello M, Boscaro M, Scanarini M, McTernan et al. Molecular genetic studies of sporadic pituitary tumors. Journal of Clinical Endocrinology and Metabolism 1994 78 387-392.
4. Landis CA, Mastyers SB, Spada A, Pace AM, Bourne HR & Vallar A. GTPase inhibiting mutations activate the α chain of Gs and stimulate adenyl cyclase in human pituitary adenomas. Nature 1989 340 692-696.
5. Atkin SL, Landolt AM, Jeffreys RV, Hipkin L, Radcliffe J & White MC. Insulin like growth factor-I has differential effects on the hormonal product of glycoprotein secreting human pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 1993 77 1059-1066.
6. Ikeda H & Yoshimoto T. The relationship between c-myc protein expression, the bromodeoxyuridine labelling index and the biological behaviour of pituitary adenomas. Acta Neuropathologica 1992 83 361-364.
7. Karga HJ, Alexander JM, Hedley-White ET, Klibanski A & Jameson JL. Ras mutations in human pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 1992 74 914-919.
8. Woloschak M, Roberts JL & Post K. c-myc, c-fos and c-myb gene expression in human pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 1994 79 253-257.
9. Kerr JFR, Wyllie AH & Currie AR. Apoptosis: A basic biological phenomenon with wide ranging implications in tissue kinetics. British Journal of Cancer 1972 26 239-257.
10. Schwartzman RA & Cidlowski JA. Apoptosis: The biochemistry and molecular biology of programmed cell death. Endocrine Reviews 1993 14 133-151.
11. Wyllie AH. Apoptosis (The 1992 Frank Rose Memorial Lecture). British Journal of Cancer 1993 67 205-208.
12. Alison MR & Sarraf CE. Apoptosis: a gene-directed programme of cell death. Journal of the Royal College of Physicians of London 1992 26 25-35.
13. Lane DP. A death in the life of p53. Nature 1993 362 786-789.
14. Levine AJ, Momand J & Finlay CA. The p53 tumour suppressor gene. Nature 1991 351 453-455.
15. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimichi A & Oren M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 1991 352 345-347.
16. Nigro JM, Baker SJ, Preisinger J M, Jessup R, Hostetter K, Cleary SH et al. Mutations in the p53 gene occur in diverse human tumor types. Nature 1989 342 705-708.
17. Hollstein M, Sidransky D, Vogelstein B & Harris CC. p53 mutations in human cancers. Science 1991 253 49-53.
18. Berchuck A, Kohler MF, Marks JR, Wiseman R, Boyd J & Bast RC. The p53 tumor suppressor gene frequently is altered in gynecologic cancers. American Journal of Obstetrics and Gynecology 1994 170 246-252.
19. Herman V, Drazin NZ, Gonsky R & Melmed S. Molecular screening of pituitary adenomas for gene mutations and rearrangements. Journal of Clinical Endocrinology and Metabolism 1993 77 50-55.
20. Sumi T, Stefaneau L, Kovacs K, Asa SL & Rindi G. Immunohistochemical study of p53 protein in human and animal pituitary tumours. Endocrine Pathology 1993 4 95-99.
21. Levy A, Hall L, Yeudall WA & Lightman S. p53 gene mutations in pituitary adenomas: rare events. Clinical Endocrinology 1994 41 809-814.
22. Thapar K, Scheithauer BW, Kovacs K, Pernicone PJ & Laws ER. p53 expression in pituitary adenomas in carcinomas: correlation with invasiveness and tumour growth fractions. Neurosurgery 1996 38 765-770.
23. Ansari B, Coates PJ, Greenstein BD & Hall PA. In Situ End Labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. Journal of Pathology 1993 170 1-8.
24. Landolt AM, Shibata T & Klehues P. Growth rate of human pituitary adenomas. Journal of Neurosurgery 1987 67 803-806.
25. Carboni P, Delta A, Hitchcock ER & Postans R. Pituitary adenoma proliferative indices and risk of recurrence. British Journal of Neurosurgery 1992 6 33-40.
26. Drewett N, Jacobi JM, Willgoss DA & Lloyd HM. Apoptosis in the anterior pituitary gland of the rat: Studies with estrogen and bromocriptine. Neuroendocrinology 1993 57 89-95.
27. Gold R, Schmed M, Giegerich G, Breitschopf H, Hartung HP, Toyka KV et al. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Laboratory Investigation 1994 71 219-225.
28. Mundle SD & Raza A. The two in situ techniques do not differentiate between apoptosis and necrosis but rather reveal distinct patterns of DNA fragmentation in apoptosis (letter). Laboratory Investigation 1995 72 611-612.
29. Buckley N, Bates AS, Broome JC, Strange RC, Perrett CW, Burke CW et al. p53 protein accumulates in Cushing's adenomas and invasive non-functional adenomas. Journal of Clinical Endocrinology and Metabolism 1994 79 1513-1517. (Erratum in Journal of Clinical Endocrinology and Metabolism 1995 80 692).
30. Vojtešek B, Bártek J, Midgley CA & Lane DP. An immunochemical analysis of the human nuclear phosphoprotein p53. Journal of Immunological Methods 1992 151 237-244.
31. White E. p53, guardian of Rb. Nature 1994 371 21-22.